Cargando…
Monotherapy with methotrexate for primary central nervous lymphoma has single agent activity in the absence of radiotherapy: a single institution cohort
We have retrospectively reviewed toxicities and response of a cohort of primary central nervous system lymphoma (PCNSL) patients treated with high dose parenteral methotrexate (MTX) monotherapy without whole brain radiation. From The Massachusetts General Hospital (MGH) Cancer Registry, active since...
Autores principales: | Cobert, Julien, Hochberg, Ephraim, Woldenberg, Nina, Hochberg, Fred |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883931/ https://www.ncbi.nlm.nih.gov/pubmed/20020180 http://dx.doi.org/10.1007/s11060-009-0090-3 |
Ejemplares similares
-
Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study
por: Lim, Daniel A., et al.
Publicado: (2009) -
Incidence of first primary central nervous system tumors in California, 2001–2005
por: Brown, Monica, et al.
Publicado: (2009) -
Incidence of first primary central nervous system tumors in California, 2001–2005: children, adolescents and teens
por: Brown, Monica, et al.
Publicado: (2009) -
Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings
por: Hilverda, Karen, et al.
Publicado: (2009) -
High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system
por: Nicolaides, Theodore, et al.
Publicado: (2009)